Statement Of Financial Position [Abstract]

Xbrane Biopharma - Filing #702448

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	30 622 SEK	—	—	—	—	—	—	—	8 166 SEK	—	—	—	—	—	—	—	—	—	—
Right-of-use assets	—	43 180 SEK	—	—	—	—	—	—	—	5 969 SEK	—	—	—	—	—	—	—	—	—	—
Goodwill	—	—	—	—	—	—	—	—	—	58 453 SEK	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	49 672 SEK	—	—	—	—	—	—	—	4 083 SEK	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	295 180 SEK	—	—	—	—	—	—	—	243 139 SEK	—	—	—	—	164 197 SEK	—	—	—	—	—
Assets	—	688 427 SEK	—	—	—	—	—	—	—	463 763 SEK	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	5 614 SEK	—	—	—	—	—	—	—	4 977 SEK	—	—	—	—	—	—	—	—	—	—
Retained earnings	—	713 313 SEK	—	—	—	—	—	—	—	524 938 SEK	—	—	—	—	—	—	—	—	—	—
Share premium	—	1 134 276 SEK	—	—	—	—	—	—	—	773 724 SEK	—	—	—	—	—	—	—	—	—	—
Other reserves	—	5 165 SEK	—	—	—	—	—	—	—	3 945 SEK	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	—	431 741 SEK	—	—	—	—	—	—	—	257 708 SEK	—	—	—	—	—	—	—	—	—	—
Equity	713 313 SEK	431 741 SEK	5 165 SEK	1 134 276 SEK	5 614 SEK	524 938 SEK	4 977 SEK	3 945 SEK	773 724 SEK	257 708 SEK	184 323 SEK	3 456 SEK	6 719 SEK	448 089 SEK	159 352 SEK	6 719 SEK	298 912 SEK	3 456 SEK	448 089 SEK	273 941 SEK
Liabilities [abstract]
Liabilities included in disposal groups classified as held for sale	—	1 257 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Liabilities	—	256 686 SEK	—	—	—	—	—	—	—	206 055 SEK	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	688 427 SEK	—	—	—	—	—	—	—	463 763 SEK	—	—	—	—	—	—	—	—	—	—